L-type Ca2+ channels mediate cardiovascular symptoms of alcohol withdrawal in humans

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 28, Issue 1, 2004, Pages 45-48

  Kähkönen, Seppo ^a,b   Bondarenko, Boris B ^c  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

^c ALMAZOV NATIONAL MEDICAL RESEARCH CENTRE   (Russian Federation)

Author keywords

Alcohol withdrawal; Blood pressure; Heart rate; L type Ca2+ channels; Verapamil

Indexed keywords

CALCIUM CHANNEL L TYPE; VERAPAMIL; ALCOHOL; CALCIUM CHANNEL BLOCKING AGENT; CENTRAL DEPRESSANT AGENT; DIAGNOSTIC AGENT;

ADULT; ALCOHOL WITHDRAWAL; ALCOHOLISM; ARTICLE; BRADYCARDIA; CARDIOVASCULAR SYMPTOM; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG BLOOD LEVEL; HEMOCONCENTRATION; HUMAN; HYPOTENSION; INJECTION; MALE; BLOOD PRESSURE; DRUG EFFECT; ELECTROCARDIOGRAPHY; HEART RATE; HEMODYNAMICS; PATHOPHYSIOLOGY; PHYSIOLOGY; WITHDRAWAL SYNDROME;

ADULT; BLOOD PRESSURE; CALCIUM CHANNEL BLOCKERS; CALCIUM CHANNELS, L-TYPE; CENTRAL NERVOUS SYSTEM DEPRESSANTS; ELECTROCARDIOGRAPHY; ETHANOL; HEART RATE; HEMODYNAMIC PROCESSES; HUMANS; MALE; SUBSTANCE WITHDRAWAL SYNDROME; VERAPAMIL;

EID: 0346995352     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0278-5846(03)00174-X     Document Type: Article

References (23)

1. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders. 3rd ed. 1987;129-130 American Psychiatric Association, Washington, DC. revised.
2. Bannan L.T., Potter J.P., Beevers D.G., Saunders J.B., Walterns J.R.F., Ingram M.C. Effect of alcohol withdrawal on blood pressure, plasma renin activity, aldosterone, cortisol and dopamine-hydrozylace. Clin. Sci. 66:1984;659-663.
3. Bone G.H., Majchrowicz E., Martin P.R., Linnoila M., Nutt D.J. A comparison of calcium antagonists and diazepam in reducing ethanol withdrawal tremors. Psychopharmacology. 99:1989;288-368.
4. Colombo G., Agabio R., Lobina C., Reali R., Melis F., Fadda F., Gessa G.L. Effects of the calcium channel antagonist darodipine on ethanol withdrawal in rats. Alcohol Alcohol. 30:1995;125-131.
5. Di Gennaro C., Vescovi P.P., Barilli A.L., Giufferedi C., Delsignore R., Motanari A. Sodium sensitivity as a main determinant of blood pressure changes during early withdrawal in heavy alcoholics. Alcohol., Clin. Exp. Res. 26:2002;1810-1815.
6. Dollery, C., 1991. Therapeutic drugs, Vol. 1, I104-I110, Vol. 2, P272-P278, V12-V19. Churchill Livingstone, Edinburg, London, Melbourne, New York, Tokyo, and Madrid.
7. Guppy L.J., Crabbe J.C., Littleton J.M. Time course and genetic variation in the regulation of calcium channel antagonist binding sites in rodent tissues during the induction of ethanol physical dependence and withdrawal. Alcohol Alcohol. 30:1995;607-615.
8. Harris H.A., Hood W.P. Inhibition of synoptosomal calcium uptake by ethanol. J. Pharmacol. Exp. Ther. 213:1980;562-567.
9. Jenkins J.S., Connolly J. Adrenocortical response to ethanol in man. Br. Med. J. 2:1968;804-805.
10. Kähkönen S. Alcohol withdrawal changes cardiovascular responses to propranolol challenge. Neuropsychobiology. 47:2003;192-197.
11. Kähkönen S., Bondarenko B.B. Cardiovascular changes in alcohol patients during withdrawal phase. Ger. J. Psychiatry. 3:2000;1-6. (Available: http://www.gjpsy.uni-goettingen.de ).
12. King A.C., Errico A.L., Parsons O.A. Blood pressure dysregulation associated with alcohol withdrawal. Alcohol., Clin. Exp. Res. 15:1991;478-482.
13. Little H.J., Dolin S.J., Halsey M.J. Calcium channel antagonists decrease the ethanol withdrawal syndrome. Life Sci. 39:1986;2059-2065.
14. Marvola M., Kannikoski A., Taskinen J., Ottoila P. Assessment of bioavailability of experimental single-unit sustained release tablets of verapamil hydrochloride using the stable isotope technique. J. Pharm. Pharmacol. 37:1985;766-770.
15. Messing R.O., Carpenter C.L., Greenberg D.A. Ethanol regulates calcium channels in clonal neural cells. P.N.A.S. 83:1986;6213-6215.
16. Murad F. Drugs used for the treatment of angina: organic nitrates, calcium-channel blockers, and β-adrenergic antagonists. Gilman A.G., Rall T.W., Nies A.S., Taylor P. Goodman and Gilman's the pharmacological basis of therapeutics. 1990;764-783 Pergamon, New York.
17. Potter J.F., Bannan L.T., Beevers D.G. The effect of a non-selective lipophilic beta-blocker on the blood pressure and noradrenaline, vasopressin, corticol and renin release during alcohol withdrawal. Clin. Exp. Hypertens. 6:1984;1147-1160.
18. 2+ channels. Am. J. Physiol. 276:1999;834-843.
19. 2+ uptake in synaptosomes and in PC12 cells. Biochem. Pharmacol. 36:1987;2227-2229.
20. 2+ channel (L-type) by protein kinase C in chronic alcohol-exposed rats. Alcohol., Clin. Exp. Res. 24:2000;1145-1152.
21. Walter H.J., Messing R.O. Regulation of neuronal voltage-gated calcium channels by ethanol. Neurochem. Int. 35:1999;95-101.
22. Worner T.M. Propranolol versus diazepam in the management of the alcohol withdrawal syndrome: double-blind controlled trial. Am. J. Drug Alcohol Abuse. 20:1994;115-124.
23. Zilm D.H., Jacob M.S., MacLeod S.M., Sellers E.M., Ti T.Y. Propranolol and chlordiazepoxide effects on cardiac arrhythmias during alcohol withdrawal. Alcohol., Clin. Exp. Res. 4:1980;400-405.